0001644062-15-000001.txt : 20150610 0001644062-15-000001.hdr.sgml : 20150610 20150610135207 ACCESSION NUMBER: 0001644062-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150610 DATE AS OF CHANGE: 20150610 EFFECTIVENESS DATE: 20150610 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Dauntless 1, Inc. CENTRAL INDEX KEY: 0001644062 IRS NUMBER: 474032770 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-241436 FILM NUMBER: 15923154 BUSINESS ADDRESS: STREET 1: 12520 HIGH BLUFF DRIVE STREET 2: SUITE 380 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-922-8919 MAIL ADDRESS: STREET 1: 12520 HIGH BLUFF DRIVE STREET 2: SUITE 380 CITY: SAN DIEGO STATE: CA ZIP: 92130 D 1 primary_doc.xml X0707 D LIVE 0001644062 Dauntless 1, Inc. 12520 HIGH BLUFF DRIVE SUITE 380 SAN DIEGO CA CALIFORNIA 92130 858-922-8919 DELAWARE None None Corporation true 2015 Joel Martin, Ph.D. c/o Dauntless 1, Inc. 12520 High Bluff Drive, Suite 380 San Diego CA CALIFORNIA 92130 Executive Officer Director David Kabakoff, Ph.D. 3000 Sand Hill Road Bldg. 4, Suite 250 Menlo Park CA CALIFORNIA 94025 Director Michael Powell, Ph.D. 3000 Sand Hill Road Bldg. 4, Suite 250 Menlo Park CA CALIFORNIA 94025 Director Pharmaceuticals Decline to Disclose 06b false 2015-05-14 false true false 0 3000195 3000195 0 The Offering Amount listed above includes Common Stock sold to founders for $195 and Series A Preferred Stock sold to investor for $3,000,000. false 4 0 0 0 false Dauntless 1, Inc. Joel F. Martin Joel F. Martin President and Chief Executive Officer 2015-06-09